Patents by Inventor Kavita Dhodapkar

Kavita Dhodapkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immune biomarkers and assays predictive of clinical response to immunotherapy for cancer
    Patent number: 9846162
    Abstract: The present invention relates to predictors of a cancer patient's responsiveness to immunotherapy for cancer.
    Type: Grant
    Filed: March 8, 2013
    Date of Patent: December 19, 2017
    Assignee: Yale University
    Inventors: Madhav Dhodapkar, Kavita Dhodapkar
  • Immunogenic epitopes as targets for universal cancer vaccines
    Patent number: 9808504
    Abstract: The present invention provides a peptide having an amino acid sequence as set forth in SEQ ID NOs: 1 through 95 and any combination thereof. The peptide or combination of peptides possess OCT4 specific inducibility. The peptide or combination of peptides can further be used as a vaccine.
    Type: Grant
    Filed: September 22, 2010
    Date of Patent: November 7, 2017
    Assignee: Yale University
    Inventors: Kavita Dhodapkar, Madhav Dhodapkar
  • Immune Biomarkers and Assays Predictive of Clinical Response to Immunotherapy for Cancer
    Publication number: 20150140017
    Abstract: The present invention relates to predictors of a cancer patient's responsiveness to immunotherapy for cancer.
    Type: Application
    Filed: March 8, 2013
    Publication date: May 21, 2015
    Inventors: Madhav Dhodapkar, Kavita Dhodapkar
  • Immunogenic Epitopes as Targets for Universal Cancer Vaccines
    Publication number: 20120207775
    Abstract: The present invention provides a peptide having an amino acid sequence as set forth in SEQ ID NOs: 1 through 95 and any combination thereof. The peptide or combination of peptides possess OCT4 specific inducibility. The peptide or combination of peptides can further be used as a vaccine.
    Type: Application
    Filed: September 22, 2010
    Publication date: August 16, 2012
    Inventors: Kavita Dhodapkar, Madhav Dhodapkar
  • Compositions and methods for enhanced dendritic cell maturation and function
    Publication number: 20070014795
    Abstract: This invention relates to compositions comprising an agent, which inhibits signaling via the Fc?RIIB receptor and an agent which stimulates or enhances signaling via an Fc?RI receptor, an Fc?RIIa receptor, an Fc?RIII receptor, or a combination thereof. The invention also provides for the use of such compositions in stimulating or enhancing an immune response, and in treating, suppressing, or preventing cancer in a subject.
    Type: Application
    Filed: December 27, 2005
    Publication date: January 18, 2007
    Inventors: Madhav Dhodapkar, Jeffrey Ravetch, Ralph Steinman, Kavita Dhodapkar